Updated Jul 16, 2026
Burroughs Amy L. has filed 2 SEC Form 4 filings across 2 companies in the last 90 days — active on both sides. Lifetime open-market purchases: $110K. Lifetime open-market sales: $3.80M.
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-05-05 | TERN | Terns Pharmaceuticals, Inc. | D — Derivative transaction | 150.0K | $53.00 | $7.95M |
| 2026-05-05 | TERN | Terns Pharmaceuticals, Inc. | J — Other acquisition / disposition | 8.3K | $53.00 | $441K |
| 2026-05-05 | TERN | Terns Pharmaceuticals, Inc. | J — Other acquisition / disposition | 146.6K | $53.00 | $7.77M |
| 2026-03-17 | TERN | Terns Pharmaceuticals, Inc. | S — Open-market sale [10b5-1] | 2.8K | $47.30 | $131K |
| 2026-03-17 | TERN | Terns Pharmaceuticals, Inc. | S — Open-market sale [10b5-1] | 11.8K | $46.57 | $550K |
| 2026-03-17 | TERN | Terns Pharmaceuticals, Inc. | M — Option exercise [10b5-1] | 14.6K | $4.64 | $68K |
| 2026-02-19 | TERN | Terns Pharmaceuticals, Inc. | S — Open-market sale [10b5-1] | 4.1K | $39.80 | $163K |
| 2026-02-19 | TERN | Terns Pharmaceuticals, Inc. | S — Open-market sale [10b5-1] | 8.2K | $39.22 | $320K |
| 2026-02-19 | TERN | Terns Pharmaceuticals, Inc. | S — Open-market sale [10b5-1] | 2.3K | $38.07 | $89K |
| 2026-02-19 | TERN | Terns Pharmaceuticals, Inc. | M — Option exercise [10b5-1] | 14.6K | $4.64 | $68K |
| 2026-01-16 | TERN | Terns Pharmaceuticals, Inc. | S — Open-market sale [10b5-1] | 7.5K | $37.53 | $282K |
| 2026-01-16 | TERN | Terns Pharmaceuticals, Inc. | S — Open-market sale [10b5-1] | 61.2K | $37.02 | $2.27M |
| 2026-01-16 | TERN | Terns Pharmaceuticals, Inc. | M — Option exercise [10b5-1] | 14.6K | $4.64 | $68K |
| 2026-01-16 | TERN | Terns Pharmaceuticals, Inc. | M — Option exercise [10b5-1] | 27.1K | $4.64 | $126K |
| 2026-01-16 | TERN | Terns Pharmaceuticals, Inc. | M — Option exercise [10b5-1] | 27.1K | $4.64 | $126K |
| 2026-01-16 | TERN | Terns Pharmaceuticals, Inc. | A — Grant or award [10b5-1] | 150.0K | $0.00 | |
| 2024-12-09 | TERN | Terns Pharmaceuticals, Inc. | P — Open-market purchase | 15.4K | $7.15 | $110K |
Burroughs Amy L. is a corporate insider — currently tracked as Insider of Tenaya Therapeutics, Inc. (TNYA). InsiderAlpha tracks every SEC Form 4 filing in real time.
2 primary Form 4 filings in the last 90 days, covering 2 companies.
Recorded transactions: 1 open-market purchases ($110K) and 7 open-market sales ($3.80M) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Burroughs Amy L. profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.